Methylprednisolone

   
Google
 
Web NewDrugInformation.com

Methylprednisolone


Drug - Methylprednisolone
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Methylprednisolone
Multiple ingredients are in alphabetical order.

Strength - 4MG
The potency of the active ingredient(s), Methylprednisolone. May repeat for multiple part products.

Applicant - SANDOZ
The firm name holding legal responsibility for Methylprednisolone. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040194
The FDA assigned number to Methylprednisolone. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Methylprednisolone. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 1997
The date Methylprednisolone was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Methylprednisolone. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Methylprednisolone is in. Format is RX, OTC, DISCN.

Applicant Full Name - Sandoz Inc
The full name of the firm holding legal responsibility for the new application of Methylprednisolone.

Methylprednisolone